These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23612383)

  • 1. Transient effect of anti-CD20 therapy in a child with 22q11.2 deletion syndrome and severe steroid refractory cytopenias: a case report.
    Soldatou A; Anastassiou T; Vougiouka O; Goussetis E; Kossiva L
    J Pediatr Hematol Oncol; 2013 May; 35(4):311-4. PubMed ID: 23612383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab for the treatment of post-bone marrow transplantation refractory hemolytic anemia in a child with Omenn's syndrome.
    Silvana B; Antonella LM; Basilia P; Trombetta D; Saija A; Salpietro C
    Pediatr Transplant; 2007 Aug; 11(5):552-6. PubMed ID: 17631027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: significant improvement after treatment with rituximab.
    Radhi M; Rumelhart S; Tatman D; Goldman F
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):125-7. PubMed ID: 17279011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of refractory donor lymphocyte infusion-induced immune-mediated pancytopenia with rituximab.
    Kato I; Umeda K; Awaya T; Yui Y; Niwa A; Fujino H; Matsubara H; Watanabe K; Heike T; Adachi N; Endo F; Mizukami T; Nunoi H; Nakahata T; Adachi S
    Pediatr Blood Cancer; 2010 Feb; 54(2):329-31. PubMed ID: 19890900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of refractory autoimmune hepatitis with rituximab.
    D'Agostino D; Costaguta A; Álvarez F
    Pediatrics; 2013 Aug; 132(2):e526-30. PubMed ID: 23821693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recurrent infections in an ITP patient treated with rituximab].
    Rosenberg-Bezalel S; Asher I; Sthoeger Z
    Harefuah; 2012 Nov; 151(11):617-9, 655. PubMed ID: 23367730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune cytopenias in the 22q11.2 deletion syndrome.
    Davies JK; Telfer P; Cavenagh JD; Foot N; Neat M
    Clin Lab Haematol; 2003 Jun; 25(3):195-7. PubMed ID: 12755799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency.
    Kim JJ; Thrasher AJ; Jones AM; Davies EG; Cale CM
    Br J Haematol; 2007 Jul; 138(1):94-6. PubMed ID: 17498197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab.
    Hongeng S; Tardtong P; Worapongpaiboon S; Ungkanont A; Jootar S
    Bone Marrow Transplant; 2002 May; 29(10):871-2. PubMed ID: 12058238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auto-immune pancytopenia in a child with DiGeorge syndrome.
    Bruno B; Barbier C; Lambilliotte A; Rey C; Turck D
    Eur J Pediatr; 2002 Jul; 161(7):390-2. PubMed ID: 12111192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brucellosis-induced autoimmune hemolytic anemia treated with rituximab.
    Bourantas LK; Pappas G; Kapsali E; Gougopoulou D; Papamichail D; Bourantas KL
    Ann Pharmacother; 2010 Oct; 44(10):1677-80. PubMed ID: 20823278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal autoimmune pancytopenia following bone marrow transplantation for aplastic anaemia.
    De Lord C; Marsh JC; Smith JG; Singer CR; Gordon-Smith EC
    Bone Marrow Transplant; 1996 Jul; 18(1):237-9. PubMed ID: 8832026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.
    Kemper MJ; Gellermann J; Habbig S; Krmar RT; Dittrich K; Jungraithmayr T; Pape L; Patzer L; Billing H; Weber L; Pohl M; Rosenthal K; Rosahl A; Mueller-Wiefel DE; Dötsch J
    Nephrol Dial Transplant; 2012 May; 27(5):1910-5. PubMed ID: 22076431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diverse clinical features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome).
    Maggadottir SM; Sullivan KE
    J Allergy Clin Immunol Pract; 2013; 1(6):589-94. PubMed ID: 24565705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case report of refractory warm autoimmune hemolytic anemia treated with plasmapheresis and rituximab.
    Aglieco F; Manickaratnam S; Bona R; Kaplan AA
    Ther Apher Dial; 2008 Apr; 12(2):185-9. PubMed ID: 18387171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders.
    Dierickx D; Delannoy A; Saja K; Verhoef G; Provan D
    Am J Hematol; 2011 Mar; 86(3):278-91. PubMed ID: 21328427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for treatment of autoimmune hemolytic anemia.
    Kuzmanovic M; Jurisic V
    Indian Pediatr; 2012 Aug; 49(8):672-4. PubMed ID: 22962244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory relapsing polychondritis in a child treated with antiCD20 monoclonal antibody (rituximab): first case report.
    Abdwani R; Kolethekkat AA; Al Abri R
    Int J Pediatr Otorhinolaryngol; 2012 Jul; 76(7):1061-4. PubMed ID: 22521002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab for the treatment of autoimmune cytopenias.
    Berentsen S
    Haematologica; 2007 Dec; 92(12):1589-96. PubMed ID: 18055980
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistent antibody depletion after rituximab in three children with autoimmune cytopenias.
    Adeli MM; Eichner BH; Thornburg C; Williams L
    Pediatr Hematol Oncol; 2009 Nov; 26(8):566-72. PubMed ID: 19954366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.